Hims & Hers Health, Inc. (HIMS) Stock Price: $28.98+1.81 (+6.66%)
The total return cagr for Hims & Hers Health, Inc. (HIMS) stock is -49.06% over the past 12 months. The 3 year average growth rate is 47.65% and the 5 year cagr is 16.60%. Total return includes dividends reinvested.
The closing share price for Hims & Hers Health, Inc. (HIMS) stock was $28.98 for Tuesday, June 9, 2026, up +6.66% from the previous day.
HIMS Price Chart
HIMS Key Metrics
See All MetricsHIMS Earnings Preview
Next Earnings Date
Aug 10, 2026
62 days away
EPS Estimate
0.08
Revenue Est.
$691.65M
Last Quarter Results
EPS
$-0.40
vs Estimate
$0.03
Revenue
$608.10M
vs Estimate
$616.84M
HIMS Analyst Ratings
Consensus Rating
Based on 14 analysts
Average Price Target
$26.61
-8.2% downside
Low
$21.00
Current
$28.98
High
$35.00
HIMS Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $0.05 | N/A | 2 |
| Q2 2027 | N/A | $0.11 | N/A | 2 |
| Q3 2027 | N/A | $0.18 | N/A | 2 |
| Q4 2027 | N/A | $0.22 | N/A | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $0.47 | N/A | 9 |
| FY 2028 | N/A | $0.79 | N/A | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $738.93M | N/A | 2 |
| Q2 2027 | N/A | $796.99M | N/A | 2 |
| Q3 2027 | N/A | $856.45M | N/A | 2 |
| Q4 2027 | N/A | $878.87M | N/A | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $3.44B | N/A | 9 |
| FY 2028 | N/A | $3.93B | N/A | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
HIMS Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1HIMS | $6.46B | $28.98 | +6.66% | -49.06% | +16.60% | N/A |
HIMS Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum